83
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Epithelioid Angiomyolipoma with Tumor Thrombus into Inferior Vena Cava Presurgically Treated with Combination Therapy of Pembrolizumab and Axitinib: A Case Report

, , , , ORCID Icon, , ORCID Icon, , & show all
Pages 447-452 | Received 30 Jun 2023, Accepted 18 Sep 2023, Published online: 05 Oct 2023

References

  • WHO Classification of Tumours Editorial Board. WHO classification of tumours of urinary and male genital tumours, 5th ed. 2022.
  • Nese N, Martignoni G, Fletcher CD, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol. 2011;35(2):161–176. doi:10.1097/PAS.0b013e318206f2a9
  • Brimo F, Robinson B, Guo C, et al. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol. 2010;34(5):715–722. doi:10.1097/PAS.0b013e3181d90370
  • Ikarashi D, Mue Y, Shiomi E, et al. Efficacy of everolimus for treating renal angiomyolipoma with inferior vena cava thrombus associated with tuberous sclerosis. Urol Case Rep. 2017;11:11–13. doi:10.1016/j.eucr.2016.12.003
  • Wagner AJ, Malinowska-Kolodziej I, Morgan JA, et al. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol. 2010;28(5):835–840. doi:10.1200/JCO.2009.25.2981
  • Italiano A, Delcambre C, Hostein I, et al. Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa. Ann Oncol. 2010;21(5):1135–1137. doi:10.1093/annonc/mdq044
  • Sanfilippo R, Jones R, Blay JY, et al. Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced Perivascular Epithelioid Cell Tumors (PEComas). Clin Cancer Res. 2019;25(17):5295–5300. doi:10.1158/1078-0432.CCR-19-0288
  • Hindi N, Sanfilippo R, Stacchiotti S, et al. Systemic therapy in perivascular epithelioid cell tumors (pecoma). Ann Oncol. 2014;25(supplement 4):494–510. doi:10.1093/annonc/mdu354.39
  • Gao F, Huang C, Zhang Y, et al. Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remarkable response of rapid progressive uterine PEComa. Cancer Biol Ther. 2016;17(6):595–598. doi:10.1080/15384047.2016.1167290
  • Lee DW, Chang H, Kim YJ, et al. Sorafenib-induced tumor response in a patient with metastatic epithelioid angiomyolipoma. J Clin Oncol. 2014;32(11):e42–5. doi:10.1200/JCO.2012.48.1960
  • AIAzab RS, Alorjani MS, Sahawneh FE, et al. Metastatic perivascular epithelioid cell tumor of the kidney: a case report with emphasis on response to the tyrosine-kinase inhibitor sunitinib. Res Rep Urol. 2019;11:311–317. doi:10.2147/RRU.S226005
  • Xu J, Gong XL, Wu H, et al. Case report: gastrointestinal PEComa with TFE3 Rearrangement treated with anti-VEGFR TKI apatinib. Front Oncol. 2020;10:582087. doi:10.3389/fonc.2020.582087
  • Zhang N, Ren Y, Zan L, et al. Case report: kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor. Front Oncol. 2022;12:966818. doi:10.3389/fonc.2022.966818
  • Gupta D, Vishwajeet V, Pandey H, et al. Epithelioid angiomyolipoma with tumor thrombus in IVC and right atrium. Autops Case Rep. 2020;10(4):E2020190. doi:10.4322/acr.2020.190
  • Que X, Zhu Y, Ye C, et al. Invasive epithelioid angiomyolipoma with tumor thrombus in the inferior vena cava: a case report and literature review. Urol Int. 2017;98(1):120–124. doi:10.1159/000434648
  • Li X, Liu R, He D. Malignant epithelioid angiomyolipoma invading the inferior vena cava: using a temporary vena cava filter to prevent tumour emboli during nephrectomy. Can Urol Assoc J. 2014;8(7–8):E564–566. doi:10.5489/cuaj.1814
  • Grant C, Lacy JM, Strup SE. A 22-year-old female with invasive epithelioid angiomyolipoma and tumor thrombus into the inferior vena cava: case report and literature review. Case Rep Urol. 2013;2013:730369. doi:10.1155/2013/730369
  • Bleeker JS, Quevedo JF, Folpe AL, et al. ”Malignant” perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma. 2012;2012:541626. doi:10.1155/2012/541626